Skip to main content

avexitide

avexitide: developed by 2 companies · 2 clinical trials tracked.

avexitide evidence translation

What we can confirm

2 tracked trials

What it means

More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about avexitide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Related indications

Post-bariatric Hypoglycemia; Post Bariatric HypoglycemiaCongenital hyperinsulinism (HI) and post-bariatric hypoglycemia (PBH)

Study sponsors

No additional listed-company sponsor is linked.

Development Pipeline (2)
CompanyPhase
Amylyx Pharmaceuticals, Inc. (AMLX)
Post-bariatric Hypoglycemia; Post Bariatric Hypoglycemia
Phase 3
Eiger BioPharmaceuticals, Inc. (EIGR)
Congenital hyperinsulinism (HI) and post-bariatric hypoglyce…
Phase 3
Clinical Trials (2)

An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric Hypoglycemia

NCT07582874·AMLX
Available
Expanded Access4 sites · United StatesAmylyx Pharmaceuticals Inc.

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Participants With Post-Bariatric Hypoglycemia

NCT06747468·Phase 3·AMLX
Active, not recruiting

Primary endpoint: Composite rate of Level 2 and Level 3 hypoglycemic events

InterventionalRandomizeddouble75 targetStarted 2025-04Completion 2027-0221 sites · United StatesAmylyx Pharmaceuticals Inc.

Frequently asked questions

Who is developing avexitide?

avexitide is being developed by Amylyx Pharmaceuticals, Inc., Eiger BioPharmaceuticals, Inc..

How many clinical trials involve avexitide?

BioSniper tracks 2 clinical trials involving avexitide.